Skip to main content
letter
. 2021 May 2;16(8):2327–2330. doi: 10.1007/s11739-021-02747-3

Table 1.

Serological tests and RNA viral detection with relative positivity observed during the study period

Number of tests performed Number of subjects (%)
Serological test for specific SARS-CoV-2 Abs IgG and IgM detection 69,343 42,911
 IgM positive results 1235 (1.8%) 904 (2.1%)
 IgG positive results 3524 (5.1%) 2132 (5.0%)
Oropharyngeal and nasopharyngeal swabs for SARS-CoV-2 RNA detection 140,965 88,771
 Positive results 8278 (5.9%) 4796 (5.4%)